Malignancy in common variable immunodeficiency: a systematic review and meta-analysis

References

• Tam JS, Routes JM. Common variable immunodeficiency. Am J Rhinol Allergy. 2013;27(4):260–265.
   PubMed Web of Science ®Google Scholar
• Saikia B, Gupta S. Common variable immunodeficiency. Indian J Pediatr. 2016;83(4):338–344.
   PubMed Web of Science ®Google Scholar
• Azizi G, Rezaei N, Kiaee F, et al. T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2016;26(4):233–243.
   PubMed Web of Science ®Google Scholar
• Azizi G, Bagheri Y, Tavakol M, et al. The clinical and immunological features of patients with primary antibody deficiencies. Endocr Metab Immune Disord Drug Targets. 2018;18(5):537–545.
   PubMed Web of Science ®Google Scholar
• Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–286.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Abolhassani H, Moazzami K, et al. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol. 2010;20(5):372–379.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Rezaei N, Gharagozlou M, et al. Hodgkin lymphoma in two siblings with common variable immunodeficiency. Pediatr Hematol Oncol. 2007;24(5):337–342.
   PubMed Web of Science ®Google Scholar
• Gompels MM, Hodges E, Lock RJ, et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol. 2003;134(2):314–320.
   PubMed Web of Science ®Google Scholar
• Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308–316.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Cooper DL, Duffy TP, et al. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002;69(3):171–178.
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495–500.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad P, Aghamohammadi A, Abolhassani H, et al. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol. 2012;22(3):208–214.
   PubMed Web of Science ®Google Scholar
• Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–1657.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Aghamohammadi A, Imanzadeh A, et al. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(2):133–134.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Hedayat M, Aghamohammadi A, et al. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127(6): 1329–41 e2. quiz 42–3.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Mao L, van Leeuwen MT, et al. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116(8):1228–1234.
   PubMed Web of Science ®Google Scholar
• Tak Manesh A, Azizi G, Heydari A, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr). 2017;45(6):602–615.
   PubMed Web of Science ®Google Scholar
• Leone P. Common variable immunodeficiency and gastric malignancies. Pediatr Blood Cancer. 2018;19:2.
   Google Scholar
• Dhalla F, Da Silva SP, Lucas M, et al. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165(1):1–7.
   PubMed Web of Science ®Google Scholar
• Mayor PC, Eng KH, Singel KL, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United states immune deficiency network registry. J Allergy Clin Immunol. 2018;141(3):1028–1035.
   PubMed Web of Science ®Google Scholar
• Aydogan M, Eifan AO, Gocmen I, et al. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications. J Investig Allergol Clin Immunol. 2008;18(4):260–265.
   PubMed Web of Science ®Google Scholar
• Bateman EA, Ayers L, Sadler R, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012;170(2):202–211.
   PubMed Web of Science ®Google Scholar
• Piquer Gibert M, Alsina L, Giner Munoz MT, et al. Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency. Eur J Pediatr. 2015;174(8):1069–1076.
   PubMed Web of Science ®Google Scholar
• Kralickova P, Milota T, Litzman J, et al. CVID-associated tumors: Czech nationwide study focused on epidemiology, immunology, and genetic background in a cohort of patients with CVID. Front Immunol. 2018;9:3135.
   PubMed Web of Science ®Google Scholar
• Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol. 2012;47(2):92–104.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602.
   PubMed Web of Science ®Google Scholar
• Abbott JK, Gelfand EW. Common variable immunodeficiency: diagnosis, management, and treatment. Immunol Allergy Clin North Am. 2015;35(4):637–658.
   PubMed Web of Science ®Google Scholar
• Wheat WH, Cool CD, Morimoto Y, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med. 2005;202(4):479–484.
   PubMed Web of Science ®Google Scholar
• Gangemi S, Allegra A, Musolino C. Lymphoproliferative disease and cancer among patients with common variable immunodeficiency. Leuk Res. 2015;39(4):389–396.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):405–408.
   PubMed Web of Science ®Google Scholar
• Sherkat R, Sabri MR, Dehghan B, et al. EBV lymphoproliferative-associated disease and primary cardiac T-cell lymphoma in a STK4 deficient patient: a case report. Medicine (Baltimore). 2017;96(48):e8852.
   PubMed Web of Science ®Google Scholar
• Sander CA, Medeiros LJ, Weiss LM, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16(12):1170–1182.
   PubMed Web of Science ®Google Scholar
• Kinlen LJ, Webster AD, Bird AG, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1(8423):263–266.
   PubMed Web of Science ®Google Scholar
• Zullo A, Romiti A, Rinaldi V, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45(1):77–81.
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101–115.
   PubMed Web of Science ®Google Scholar
• Turesson C, Matteson EL. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford). 2013;52(1):5–14.
   PubMed Web of Science ®Google Scholar
• Giat E, Ehrenfeld M, Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun Rev. 2017;16(10):1049–1057.
   PubMed Web of Science ®Google Scholar
• Dasanu CA, Bockorny B, Grabska J, et al. Prevalence and pattern of autoimmune conditions in patients with marginal zone lymphoma: a single institution experience. Connecticut Med. 2015;79(4):197–200.
   PubMedGoogle Scholar
• Zaenker P, Gray ES, Ziman MR. Autoantibody production in cancer–the humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15(5):477–483.
   PubMed Web of Science ®Google Scholar
• Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Immunol. 2003;21:807–839.
   PubMed Web of Science ®Google Scholar
• Filaci G, Fravega M, Setti M, et al. Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. Blood. 2006;107(4):1505–1512.
   PubMed Web of Science ®Google Scholar
• Forsberg O, Carlsson B, Malmstrom PU, et al. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals. Prostate. 2009;69(1):70–81.
   PubMed Web of Science ®Google Scholar
• Weynants P, Thonnard J, Marchand M, et al. Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival. Am J Respir Crit Care Med. 1999;159(1):55–62.
   PubMed Web of Science ®Google Scholar
• Bossi G, Trambas C, Booth S, et al. The secretory synapse: the secrets of a serial killer. Immunol Rev. 2002;189:152–160.
   PubMed Web of Science ®Google Scholar
• Durgeau A, Virk Y, Corgnac S, et al. Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy. Front Immunol. 2018;9:14.
   PubMed Web of Science ®Google Scholar
• Walter U, Santamaria P. CD8+ T cells in autoimmunity. Curr Opin Immunol. 2005;17(6):624–631.
   PubMed Web of Science ®Google Scholar
• Liblau RS, Wong FS, Mars LT, et al. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity. 2002;17(1):1–6.
   PubMed Web of Science ®Google Scholar
• Yang W, Agrawal N, Patel J, et al. Diminished expression of CD19 in B-cell lymphomas. Cytometry B Clin Cytom. 2005;63(1):28–35.
   PubMedGoogle Scholar
• Cabezudo E, Carrara P, Morilla R, et al. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Haematologica. 1999;84(5):413–418.
   PubMed Web of Science ®Google Scholar
• Hong WS, Hong SI, Kim CM, et al. Differential depression of lymphocyte subsets according to stage in stomach cancer. Jpn J Clin Oncol. 1991;21(2):87–93.
   PubMed Web of Science ®Google Scholar
• Amlot PL, Green L. Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. Br J Cancer. 1979;40(3):371–379.
   PubMed Web of Science ®Google Scholar
• Lichtenstein A, Taylor CR. Serum immunoglobulin levels in patients with non-Hodgkin’s lymphoma. Am J Clin Pathol. 1980;74(1):12–17.
   PubMed Web of Science ®Google Scholar
• Saito T, Kuwahara A, Kinoshita T, et al. Increases in immunoglobulin and complement in patients with esophageal or gastric cancer. Surg Today. 1992;22(6):537–542.
   PubMed Web of Science ®Google Scholar
• Alkhairy OK, Perez-Becker R, Driessen GJ, et al. Novel mutations in TNFRSF7/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015;136(3):703–12 e10.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Edwards ES, Ikinciogullari A, et al. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017;214(1):91–106.
   PubMed Web of Science ®Google Scholar
• Maccari ME, Abolhassani H, Aghamohammadi A, et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Delta Syndrome registry. Front Immunol. 2018;9:543.
   PubMed Web of Science ®Google Scholar
• Fliegauf M, Bryant VL, Frede N, et al. Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389–403.
   PubMed Web of Science ®Google Scholar
• Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385–400.
   PubMed Web of Science ®Google Scholar
• Ardeniz O, Basoglu OK, Gunsar F, et al. Clinical and immunological analysis of 23 adult patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010;20(3):222–236.
   PubMed Web of Science ®Google Scholar
• Herbst EW, Armbruster M, Rump JA, et al. Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol. 1994;95(2):215–221.
   PubMed Web of Science ®Google Scholar
• Seve P, Bourdillon L, Sarrot-Reynauld F, et al. Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore). 2008;87(3):177–184.
   PubMed Web of Science ®Google Scholar
• Ramyar A, Aghamohammadi A, Moazzami K, et al. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008;7(3):169–175.
   PubMed Web of Science ®Google Scholar
• Furudoi A, Gros A, Stanislas S, et al. Spleen histologic appearance in common variable immunodeficiency: analysis of 17 Cases. Am J Surg Pathol. 2016;40(7):958–967.
   PubMed Web of Science ®Google Scholar
• Vlkova M, Ticha O, Nechvatalova J, et al. Regulatory B cells in CVID patients fail to suppress multifunctional IFN-gamma+ TNF-alpha+ CD4+ T cells differentiation. Clin Immunol. 2015;160(2):292–300.
   PubMed Web of Science ®Google Scholar